Meropenem and Hospitalisation - a phase IV clinical study of FDA data
Summary:
Hospitalisation is reported as a side effect among people who take Meropenem (meropenem), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Pulmozyme, and have Cystic fibrosis.
The phase IV clinical study analyzes which people have Hospitalisation when taking Meropenem. It is created by eHealthMe based on reports of 33,250 people who have side effects when taking Meropenem from the FDA, and is updated regularly.
What is Meropenem?
Meropenem has active ingredients of meropenem. eHealthMe is studying from 33,295 Meropenem users. Check the latest studies of Meropenem.
What is Hospitalisation?
Hospitalisation is found to be associated with 1,716 drugs and 1,135 conditions by eHealthMe. Check the latest studies of Hospitalisation.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
33,250 people reported to have side effects when taking Meropenem.
Among them, 39 people (0.12%) have Hospitalisation.

Among these 39 people:
How long have people been on Meropenem when they have Hospitalisation? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Hospitalisation when taking Meropenem? *
- female: 41.03 %
- male: 58.97 %
What is the age of people who have Hospitalisation when taking Meropenem? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 4.35 %
- 20-29: 4.35 %
- 30-39: 26.09 %
- 40-49: 8.7 %
- 50-59: 26.09 %
- 60+: 30.43 %
What are other drugs people take besides Meropenem? *
- Pulmozyme: 8 people, 20.51%
- Cefepime Hydrochloride: 6 people, 15.38%
- Humalog: 6 people, 15.38%
- Azacitidine: 6 people, 15.38%
- Zovirax: 5 people, 12.82%
- Vancomycin: 5 people, 12.82%
- Creon: 5 people, 12.82%
- Venclexta: 5 people, 12.82%
- Tamsulosin: 5 people, 12.82%
- Ativan: 5 people, 12.82%
What are other side effects people have besides Hospitalisation? *
- Thrombocytopenia (decrease of platelets in blood): 8 people, 20.51%
- Septic Shock (shock due to blood infection): 5 people, 12.82%
- Infection: 4 people, 10.26%
- Abdominal Pain: 4 people, 10.26%
- Fatigue (feeling of tiredness): 3 people, 7.69%
- Kidney Stones: 3 people, 7.69%
- Renal Disorder (kidney disease): 3 people, 7.69%
- Pneumonia: 3 people, 7.69%
- Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 3 people, 7.69%
- Death: 3 people, 7.69%
What are the existing conditions these people have? *
- Cystic Fibrosis (disease of the secretary glands): 13 people, 33.33%
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 8 people, 20.51%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 5 people, 12.82%
- Malignant Melanoma (skin cancer rises from melancytes): 1 person, 2.56%
- Cerebral Disorder (brain disease): 1 person, 2.56%
- Cor Pulmonale Chronic (long lasting enlargement of the right ventricle of the heart): 1 person, 2.56%
- Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 2.56%
- Fungal Infection: 1 person, 2.56%
- High Blood Cholesterol: 1 person, 2.56%
- Hyperkalemia (damage to or disease of the kidney): 1 person, 2.56%
* Approximation only. Some reports may have incomplete information.
Do you take Meropenem and have Hospitalisation?
- Check whether Hospitalisation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Meropenem:
- Meropenem (33,295 reports)
Hospitalisation treatments and more:
- Hospitalisation (143,651 reports)
How severe was Hospitalisation and when was it recovered:
Expand to all the drugs that have ingredients of meropenem:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Meropenem:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hospitalisation:
- Hospitalisation (1,716 drugs)
Browse all the conditions that are associated with Hospitalisation:
- Hospitalisation (1,135 conditions)
Related publications that referenced our studies
- Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
- Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on meropenem (the active ingredients of Meropenem) and Meropenem (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Zeposia and Ms for Men aged 50-59 - 18 seconds ago
- Zeposia and Ms Hug for Men aged 50-59 - 18 seconds ago
- Zeposia and Multiple Sclerosis for Men aged 50-59 - 19 seconds ago
- Could Wellbutrin Sr cause Hypothyroidism? - 22 seconds ago
- Ibuprofen and Haemodynamic Instability for Men aged 20-29 - 27 seconds ago
- Could Pantoprazole cause Carcinoembryonic Antigen Increased? - 47 seconds ago
- Lopurin and Pulmonary Hypertension for Boys aged 2-9 - 51 seconds ago
- Lopurin and Pulmonary Hypertension for Men aged 50-59 - 54 seconds ago
- Lopurin and Cardiac Murmur for Women aged 50-59 - 56 seconds ago
- Could Famotidine cause Tooth Erosion? - a minute ago